Benmelstobart in Combination With Anlotinib and Oral Metronomic Cyclophosphamide in the Treatment of Recurrent Epithelial OvariaN, Fallopian Tube, or Primary Peritoneal Cancer

Clinical trial NCT07489300 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07489300
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Fallopian Tube Cancers Primary Peritoneal Cancer

Start date: 2026-03-30
Primary completion: 2027-01-31
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.